Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 7, 2004, Pages 869-875

  Ho, W S Vanessa ^b   Hiley, C Robin ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; APAMIN; CALCIUM CHANNEL; CALCIUM ION; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; CHARYBDOTOXIN; INDOMETACIN; METHOXAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; RIMONABANT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VIRODHAMINE;

ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DESENSITIZATION; DRUG ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME INHIBITION; MALE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; ENDOTHELIUM, VASCULAR; MALE; MESENTERIC ARTERIES; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, DRUG; VASODILATION;

EID: 3042818259     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357023682     Document Type: Article

References (32)

1. Barg, J., Fride, E., Hanus, L., Levy, R., Matus-Leibovitch, N., Heldman, E., Bayewitch, M., Mechoulam, R., Vogel, Z. (1995) Cannabinomimetic behavioural effects of and adenylyl cyclase inhibition by two new endogenous anandamides. Eur. J. Pharmacol. 287: 145-152
2. +-current. J. Biol. Chem. 278: 46188-46194
3. 1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem. J. 351: 817-824
4. 1 receptor-deficient mice. Hypertension 39: 251-257
5. Busse, R., Edwards, G., Feletou, M., Fleming, I., Vanhoutte, P. M., Weston, A. H. (2002) EDHF: bringing the concepts together. Trends Pharmacol. Sci. 23: 374-380
6. 1) receptor expression is associated with mesenteric resistance vessels but not thoracic aorta in the rat. Br. J. Pharmacol. 125: 95P
7. De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Pertwee, R. G., Di Marzo, V. (2000) Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett. 483: 52-56
8. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griff, C., Gibson, D., Mandelbaum, A., Etinger, A., Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949
9. Goparaju, S. K., Ueda, N., Yamaguchi, H., Yamamoto, S. (1998) Anandamide aminohydrolase reacting with 2-arachidonylglycerol, another cannabinoid receptor ligand. FEBS Lett. 42: 69-73
10. Gough, W., Bensinger, J. W., Li, J., Baker, A., Porter, A. C. (2003) Pharmacological characterisation of five endogenous cannabinoids. 2003 Symposium on the Cannabinoids. International Cannabinoid Research Society, Burlington, Vermont, 80 pp
11. Harris, D., McCulloch, A. I., Kendall, D. A., Randall, M. D. (2002) Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J. Physiol. 539: 893-902
12. Hiley, C. R., Ford, W. R. (2004) Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling. Biol. Rev. 79: 187-205
13. Ho, W.-S.V., Hiley, C. R. (2003a) Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. Br. J. Pharmacol. 138: 1320-1332
14. 2+ influx. Br. J. Pharmacol. 139: 585-597
15. 2 receptors. Proc. Natl. Acad. Sci. USA 96: 14136-14141
16. Kagota, S., Yamaguchi, Y., Nakamura, K., Sugiura, T., Waku, K., Kunitomo, M. (2001) 2-Arachidonylglycerol, a candidate of endothelium-derived hyperpolarizing factor. Eur. J. Pharmacol. 415: 233-238
17. Lan, R., Liu, Q., Fan, P., Lin, S., Fernando, S. R., McCallion, D., Pertwee, R., Makriyannis, A. (1999) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem. 42: 769-776
18. 1 receptor knockout mice. Science 283: 401-404
19. Markey, S. P., Duddin, T., Wang, T.-C. L. (2000) Base- and acid-catalysed interconvertions of O-acyl- and N-acyl-ethanolamines: a cautionary note for lipid analysis. J. Lipid. Res. 41: 657-662
20. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., Pertwee, R. G., Griffin, G., Bayewitch, M., Barg, J., Vogel, Z. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50: 83-90
21. Offertáler, L., Mo, F.-M., Bátkai, S., Liu, J., Begg, M., Razdan, R. K., Martin, B. R., Bukoski, R. D., Kunos, G. (2003) Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol. Pharmacol. 63: 699-705
22. O'Sullivan, S. E., Kendall, D. A., Randall, M. D. (2004) Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA). Br. J. Pharmacol. 141: 803-812
23. 1 receptor. J. Pharmacol. Exp. Ther. 301: 1020-1024
24. Randall, M. D., Harris, D., Kendall, D. A., Ralevic, V. (2002) Cardiovascular effects of cannabinoids. Pharmacol. Ther. 95: 191-202
25. 2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284: 644-650
26. 2 cannabinoid receptors of L759633, L759656 and AM630. Br. J. Pharmacol. 126: 665-672
27. 2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278: 989-999
28. Wagner, J. A., Varga, K., Járai, Z., Kunos, G. (1999) Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 33: 429-434
29. White, R., Hiley, C. R. (1997) A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br. J. Pharmacol. 122: 1573-1584
30. White, R., Hiley, C. R. (1998) The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery. Br. J. Pharmacol. 125: 689-696
31. White, R., Ho, W.-S. V., Bottrill, F. E., Ford, W. R., Hiley, C. R. (2001) Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br. J. Pharmacol. 134: 921-929
32. Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H., Sørgård, M., Di Marzo, V., Julius D., Högestätt, E. D. (1999) Vanilloid receptors on sensory nerves mediate vasodilator action of anandamide. Nature 400: 452-457